Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.53 - $0.93 $207,470 - $364,052
391,454 Added 13.53%
3,285,071 $1.91 Million
Q4 2023

Feb 13, 2024

BUY
$0.63 - $1.14 $338,182 - $611,948
536,797 Added 22.78%
2,893,617 $2.4 Million
Q3 2023

May 14, 2024

SELL
$1.12 - $1.88 $601,212 - $1.01 Million
-536,797 Reduced 18.55%
2,356,820 $2.66 Million
Q3 2023

Nov 14, 2023

SELL
$1.12 - $1.88 $990,932 - $1.66 Million
-884,761 Reduced 27.29%
2,356,820 $2.66 Million
Q2 2023

May 14, 2024

SELL
$1.31 - $2.04 $347,125 - $540,561
-264,981 Reduced 7.56%
3,241,581 $5.19 Million
Q2 2023

Aug 14, 2023

SELL
$1.31 - $2.04 $347,125 - $540,561
-264,981 Reduced 7.56%
3,241,581 $5.19 Million
Q1 2023

May 14, 2024

BUY
$1.45 - $2.95 $1.92 Million - $3.9 Million
1,320,833 Added 60.43%
3,506,562 $5.33 Million
Q1 2023

May 11, 2023

BUY
$1.45 - $2.95 $1.92 Million - $3.9 Million
1,320,833 Added 60.43%
3,506,562 $5.33 Million
Q4 2022

May 14, 2024

BUY
$2.02 - $3.25 $1.61 Million - $2.6 Million
798,475 Added 57.56%
2,185,729 $5.25 Million
Q4 2022

Feb 13, 2023

BUY
$2.02 - $3.25 $1.61 Million - $2.6 Million
798,475 Added 57.56%
2,185,729 $5.25 Million
Q3 2022

May 14, 2024

SELL
$1.96 - $3.14 $2.05 Million - $3.29 Million
-1,047,142 Reduced 43.01%
1,387,254 $2.84 Million
Q3 2022

Nov 10, 2022

SELL
$1.96 - $3.14 $2.05 Million - $3.29 Million
-1,047,142 Reduced 43.01%
1,387,254 $2.84 Million
Q2 2022

May 14, 2024

SELL
$1.3 - $2.64 $596,987 - $1.21 Million
-459,221 Reduced 15.87%
2,434,396 $4.72 Million
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.64 $1.18 Million - $2.41 Million
911,006 Added 59.8%
2,434,396 $4.72 Million
Q1 2022

May 16, 2022

SELL
$2.35 - $3.47 $3.05 Million - $4.51 Million
-1,299,939 Reduced 46.04%
1,523,390 $3.75 Million
Q4 2021

Feb 14, 2022

BUY
$2.92 - $5.74 $4.59 Million - $9.03 Million
1,572,819 Added 125.77%
2,823,329 $9.09 Million
Q3 2021

Nov 10, 2021

BUY
$4.98 - $6.63 $6.23 Million - $8.29 Million
1,250,510 New
1,250,510 $6.57 Million

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.